RxDoctor Payments Data

Kristen Hammes

Nurse Practitioner · Omaha, NENPI 1891801254

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $795,501 of the $899,320 with a category attached, or 88.5%. AbbVie accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $249,965 and has fallen 66.7% since, to $83,186 in 2025. Among nurse practitioner clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$899,320in general payments, 2019–2025

Across 1,100 payments — averaging $817.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$899K
  • Galderma Laboratories, L.p.$140
  • Alk-abello, Inc$26

What the payments were for

  • Consulting fees$1,5050%
  • Speaking & faculty fees$795,50188%
  • Travel & lodging$90,79510%
  • Food & beverage$11,4951%
  • Education$240%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)1,095$899,153
Galderma Laboratories, L.p.3$140
Alk-abello, Inc2$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$899,320 in reported general payments places this provider in the 95th percentile of 924 nurse practitioner providers in Nebraska.

See all nurse practitioner providers in Nebraska

Other nurse practitioner in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →